[go: up one dir, main page]

GB201703453D0 - Therapy - Google Patents

Therapy

Info

Publication number
GB201703453D0
GB201703453D0 GBGB1703453.9A GB201703453A GB201703453D0 GB 201703453 D0 GB201703453 D0 GB 201703453D0 GB 201703453 A GB201703453 A GB 201703453A GB 201703453 D0 GB201703453 D0 GB 201703453D0
Authority
GB
United Kingdom
Prior art keywords
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1703453.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aslan Pharmaceuticals Pte Ltd
Original Assignee
Aslan Pharmaceuticals Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aslan Pharmaceuticals Pte Ltd filed Critical Aslan Pharmaceuticals Pte Ltd
Priority to GBGB1703453.9A priority Critical patent/GB201703453D0/en
Publication of GB201703453D0 publication Critical patent/GB201703453D0/en
Priority to PCT/SG2018/050092 priority patent/WO2018160138A1/en
Priority to EP18717448.7A priority patent/EP3589286B1/en
Priority to TW107106747A priority patent/TW201834649A/en
Priority to US16/154,422 priority patent/US11382903B2/en
Priority to US16/252,452 priority patent/US11311548B2/en
Ceased legal-status Critical Current

Links

GBGB1703453.9A 2017-03-02 2017-03-02 Therapy Ceased GB201703453D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB1703453.9A GB201703453D0 (en) 2017-03-02 2017-03-02 Therapy
PCT/SG2018/050092 WO2018160138A1 (en) 2017-03-02 2018-03-01 Dhodh inhibitor for treating haematological cancer
EP18717448.7A EP3589286B1 (en) 2017-03-02 2018-03-01 Dhodh inhibitor for treating haematological cancer
TW107106747A TW201834649A (en) 2017-03-02 2018-03-01 Cancer therapy
US16/154,422 US11382903B2 (en) 2017-03-02 2018-10-08 Cancer therapy
US16/252,452 US11311548B2 (en) 2017-03-02 2019-01-18 Cancer therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1703453.9A GB201703453D0 (en) 2017-03-02 2017-03-02 Therapy

Publications (1)

Publication Number Publication Date
GB201703453D0 true GB201703453D0 (en) 2017-04-19

Family

ID=58543967

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1703453.9A Ceased GB201703453D0 (en) 2017-03-02 2017-03-02 Therapy

Country Status (1)

Country Link
GB (1) GB201703453D0 (en)

Similar Documents

Publication Publication Date Title
GB201707153D0 (en) Therapy
GB201719646D0 (en) Therapy
GB201708663D0 (en) Therapy
IL272560A (en) Combination therapy
GB201715430D0 (en) Therapy
GB201707945D0 (en) Cnacer therapy
GB201707183D0 (en) Macrophage-based therapy
GB201703453D0 (en) Therapy
GB201703070D0 (en) Therapy
GB201706228D0 (en) Combination therapy
GB201706234D0 (en) Combination therapy
GB201706245D0 (en) Combination therapy
GB201706247D0 (en) Combination therapy
GB201706259D0 (en) Combination therapy
GB201706238D0 (en) Combination therapy
GB201706258D0 (en) Combination therapy
GB201706257D0 (en) Combination therapy
GB201706256D0 (en) Combination therapy
GB201706221D0 (en) Combination therapy
GB201706222D0 (en) Combination therapy
GB201706223D0 (en) Combination therapy
GB201706224D0 (en) Combination therapy
GB201706225D0 (en) Combination therapy
GB201706227D0 (en) Combination therapy
GB201706226D0 (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)